- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Namaste Technologies announced its subsidiary Cannmart completed Health Canada’s pre-sales license inspection for its facility in Etobicoke, Ontario.
Namaste Technologies (TSXV:N) announced its subsidiary Cannmart completed Health Canada’s pre-sales license inspection for its facility in Etobicoke, Ontario.
As quoted in the press release:
On July 31, 2018, Health Canada inspectors were on-site to verify information submitted by Cannmart as part of its application and in assessing compliance with the applicable sections of the ACMPR prior to license approval. The Pre-Sales License Inspection is one of the last steps prior to the issuance of a Sales License under the ACMPR.
Cannmart’s ACMPR “sales-only” license will be the first of its kind in Canada. The license enables Namaste to aggregate cannabis strains from licensed producers across the country, with the goal of offering medical patients access to the largest variety of medical cannabis products in a single platform. Namaste has positioned itself as a leader in the development of innovative cannabis e-commerce technology and will leverage its expertise and its platform powered by the Company’s wholly-owned subsidiary and AI technology company, Findify AB (“Findify” or “Findify.io”) to offer medical patients the most personalized user experience possible.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.